Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
21 01 2021
Historique:
received: 06 10 2020
accepted: 01 01 2021
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 6 10 2021
Statut: epublish

Résumé

Diabetes patients without obstructive coronary artery disease as assessed by coronary angiography have a low risk of myocardial infarction, but their myocardial infarction risk may still be higher than the general population. We examined the 10-year risks of myocardial infarction, ischemic stroke, and death in diabetes patients without obstructive coronary artery disease according to coronary angiography, compared to risks in a matched general population cohort. We included all diabetes patients without obstructive coronary artery disease examined by coronary angiography from 2003 to 2016 in Western Denmark. Patients were matched by age and sex with a cohort from the Western Denmark general population without a previous myocardial infarction or coronary revascularization. Outcomes were myocardial infarction, ischemic stroke, and death. Ten-year cumulative incidences were computed. Adjusted hazard ratios (HR) then were computed using stratified Cox regression with the general population as reference. We identified 5734 diabetes patients without obstructive coronary artery disease and 28,670 matched individuals from the general population. Median follow-up was 7 years. Diabetes patients without obstructive coronary artery disease had an almost similar 10-year risk of myocardial infarction (3.2% vs 2.9%, adjusted HR 0.93, 95% CI 0.72-1.20) compared to the general population, but had an increased risk of ischemic stroke (5.2% vs 2.2%, adjusted HR 1.87, 95% CI 1.47-2.38) and death (29.6% vs 17.8%, adjusted HR 1.24, 95% CI 1.13-1.36). Patients with diabetes and no obstructive coronary artery disease have a 10-year risk of myocardial infarction that is similar to that found in the general population. However, they still remain at increased risk of ischemic stroke and death.

Sections du résumé

BACKGROUND
Diabetes patients without obstructive coronary artery disease as assessed by coronary angiography have a low risk of myocardial infarction, but their myocardial infarction risk may still be higher than the general population. We examined the 10-year risks of myocardial infarction, ischemic stroke, and death in diabetes patients without obstructive coronary artery disease according to coronary angiography, compared to risks in a matched general population cohort.
METHODS
We included all diabetes patients without obstructive coronary artery disease examined by coronary angiography from 2003 to 2016 in Western Denmark. Patients were matched by age and sex with a cohort from the Western Denmark general population without a previous myocardial infarction or coronary revascularization. Outcomes were myocardial infarction, ischemic stroke, and death. Ten-year cumulative incidences were computed. Adjusted hazard ratios (HR) then were computed using stratified Cox regression with the general population as reference.
RESULTS
We identified 5734 diabetes patients without obstructive coronary artery disease and 28,670 matched individuals from the general population. Median follow-up was 7 years. Diabetes patients without obstructive coronary artery disease had an almost similar 10-year risk of myocardial infarction (3.2% vs 2.9%, adjusted HR 0.93, 95% CI 0.72-1.20) compared to the general population, but had an increased risk of ischemic stroke (5.2% vs 2.2%, adjusted HR 1.87, 95% CI 1.47-2.38) and death (29.6% vs 17.8%, adjusted HR 1.24, 95% CI 1.13-1.36).
CONCLUSIONS
Patients with diabetes and no obstructive coronary artery disease have a 10-year risk of myocardial infarction that is similar to that found in the general population. However, they still remain at increased risk of ischemic stroke and death.

Identifiants

pubmed: 33478504
doi: 10.1186/s12933-021-01212-x
pii: 10.1186/s12933-021-01212-x
pmc: PMC7819163
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Références

Circ Cardiovasc Imaging. 2014 Mar;7(2):282-91
pubmed: 24550435
Heart Vessels. 2019 Jul;34(7):1086-1095
pubmed: 30635712
Clin Epidemiol. 2016 Oct 19;8:415-423
pubmed: 27799822
BMJ Open. 2017 Jul 31;7(7):e015949
pubmed: 28760792
Am J Cardiol. 2019 Jan 1;123(1):153-158
pubmed: 30389089
Cardiovasc Diabetol. 2019 Apr 23;18(1):51
pubmed: 31014330
JAMA. 2014 Nov 5;312(17):1754-63
pubmed: 25369489
J Am Heart Assoc. 2020 May 5;9(9):e014954
pubmed: 32345133
Arch Intern Med. 2002 Aug 12-26;162(15):1737-45
pubmed: 12153377
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123
pubmed: 30559236
Neuroepidemiology. 2007;28(3):150-4
pubmed: 17478969
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Diabetes Care. 1997 Jun;20(6):935-42
pubmed: 9167103
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
Diabetologia. 2004 Jan;47(1):145-6
pubmed: 14676943
Atherosclerosis. 2015 Apr;239(2):335-42
pubmed: 25682032
PLoS One. 2018 Dec 12;13(12):e0207194
pubmed: 30540755
J Am Coll Cardiol. 2018 Mar 20;71(11):1259-1272
pubmed: 29544611
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1271-1278
pubmed: 31220229
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
N Engl J Med. 2018 Oct 18;379(16):1529-1539
pubmed: 30146931
Circ Cardiovasc Imaging. 2014 Jul;7(4):629-38
pubmed: 24906356
Diabetes Obes Metab. 2018 Mar;20(3):723-729
pubmed: 28950045
Cardiovasc Diabetol. 2019 Feb 28;18(1):22
pubmed: 30819191
Int J Cardiol. 2018 Jun 15;261:18-23
pubmed: 29563017
Diabetes Metab. 2012 Nov;38(5):420-7
pubmed: 22682738
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Stat Sci. 2010 Feb 1;25(1):1-21
pubmed: 20871802
JACC Cardiovasc Interv. 2015 Sep;8(11):1445-53
pubmed: 26404197
Circ Res. 2016 May 27;118(11):1723-35
pubmed: 27230638
J Am Coll Cardiol. 2017 Jan 31;69(4):409-419
pubmed: 28126158
Lancet. 2018 Sep 22;392(10152):1036-1046
pubmed: 30158069
Diabetes Care. 2017 Aug;40(8):1103-1110
pubmed: 28596210
Diabetes Res Clin Pract. 2008 Oct;82(1):139-47
pubmed: 18703252
Diabetes Care. 2020 Jan;43(Suppl 1):S111-S134
pubmed: 31862753
JAMA. 2019 Jan 22;321(3):277-287
pubmed: 30667501
Stroke. 2012 May;43(5):1212-7
pubmed: 22382158

Auteurs

Kevin Kris Warnakula Olesen (KKW)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. kevole@clin.au.dk.
Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N, 8200, Denmark. kevole@clin.au.dk.
Department of Cardiology, Viborg Regional Hospital, Heibergs Allé 4A, Viborg, 8800, Denmark. kevole@clin.au.dk.

Morten Madsen (M)

Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N, 8200, Denmark.

Christine Gyldenkerne (C)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Pernille Gro Thrane (PG)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Troels Thim (T)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Lisette Okkels Jensen (LO)

Department of Cardiology, Odense University Hospital, J.B. Winsløws Vej 4, Odense, 5000, Denmark.

Hans Erik Bøtker (HE)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Henrik Toft Sørensen (HT)

Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N, 8200, Denmark.

Michael Maeng (M)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH